Seek Returns logo

KO vs. LLY: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at KO and LLY, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolKOLLY
Company NameThe Coca-Cola CompanyEli Lilly and Company
CountryUnited StatesUnited States
GICS SectorConsumer StaplesHealth Care
GICS IndustryBeveragesPharmaceuticals
Market Capitalization287.40 billion USD739.95 billion USD
ExchangeNYSENYSE
Listing DateJanuary 2, 1962June 1, 1972
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of KO and LLY by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

KO vs. LLY: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolKOLLY
5-Day Price Return1.21%2.85%
13-Week Price Return-6.82%-2.12%
26-Week Price Return-5.60%-7.71%
52-Week Price Return-7.07%-13.08%
Month-to-Date Return0.69%4.15%
Year-to-Date Return7.26%-1.17%
10-Day Avg. Volume16.78M4.02M
3-Month Avg. Volume15.89M4.14M
3-Month Volatility13.32%41.96%
Beta0.400.41

Profitability

Return on Equity (TTM)

KO

45.90%

Beverages Industry

Max
45.90%
Q3
22.74%
Median
10.10%
Q1
6.35%
Min
-13.21%

In the upper quartile for the Beverages industry, KO’s Return on Equity of 45.90% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

LLY

88.36%

Pharmaceuticals Industry

Max
38.59%
Q3
19.84%
Median
11.85%
Q1
5.40%
Min
-10.91%

LLY’s Return on Equity of 88.36% is exceptionally high, placing it well beyond the typical range for the Pharmaceuticals industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

KO vs. LLY: A comparison of their Return on Equity (TTM) against their respective Beverages and Pharmaceuticals industry benchmarks.

Net Profit Margin (TTM)

KO

25.89%

Beverages Industry

Max
21.38%
Q3
12.24%
Median
8.43%
Q1
5.97%
Min
0.65%

KO’s Net Profit Margin of 25.89% is exceptionally high, placing it well beyond the typical range for the Beverages industry. This demonstrates outstanding operational efficiency and a strong competitive advantage in converting revenue into profit.

LLY

25.91%

Pharmaceuticals Industry

Max
40.67%
Q3
19.07%
Median
12.31%
Q1
4.50%
Min
-9.91%

A Net Profit Margin of 25.91% places LLY in the upper quartile for the Pharmaceuticals industry, signifying strong profitability and more effective cost management than most of its peers.

KO vs. LLY: A comparison of their Net Profit Margin (TTM) against their respective Beverages and Pharmaceuticals industry benchmarks.

Operating Profit Margin (TTM)

KO

29.32%

Beverages Industry

Max
29.32%
Q3
20.15%
Median
13.14%
Q1
10.74%
Min
1.24%

An Operating Profit Margin of 29.32% places KO in the upper quartile for the Beverages industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

LLY

32.37%

Pharmaceuticals Industry

Max
45.78%
Q3
23.14%
Median
16.68%
Q1
7.98%
Min
-7.13%

An Operating Profit Margin of 32.37% places LLY in the upper quartile for the Pharmaceuticals industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

KO vs. LLY: A comparison of their Operating Profit Margin (TTM) against their respective Beverages and Pharmaceuticals industry benchmarks.

Profitability at a Glance

SymbolKOLLY
Return on Equity (TTM)45.90%88.36%
Return on Assets (TTM)11.80%16.02%
Net Profit Margin (TTM)25.89%25.91%
Operating Profit Margin (TTM)29.32%32.37%
Gross Profit Margin (TTM)61.43%82.64%

Financial Strength

Current Ratio (MRQ)

KO

1.21

Beverages Industry

Max
3.52
Q3
2.00
Median
1.22
Q1
0.87
Min
0.55

KO’s Current Ratio of 1.21 aligns with the median group of the Beverages industry, indicating that its short-term liquidity is in line with its sector peers.

LLY

1.28

Pharmaceuticals Industry

Max
4.65
Q3
2.64
Median
1.85
Q1
1.26
Min
0.78

LLY’s Current Ratio of 1.28 aligns with the median group of the Pharmaceuticals industry, indicating that its short-term liquidity is in line with its sector peers.

KO vs. LLY: A comparison of their Current Ratio (MRQ) against their respective Beverages and Pharmaceuticals industry benchmarks.

Debt-to-Equity Ratio (MRQ)

KO

1.73

Beverages Industry

Max
2.14
Q3
1.14
Median
0.74
Q1
0.37
Min
0.00

KO’s leverage is in the upper quartile of the Beverages industry, with a Debt-to-Equity Ratio of 1.73. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.

LLY

2.18

Pharmaceuticals Industry

Max
1.75
Q3
0.82
Median
0.35
Q1
0.13
Min
0.00

With a Debt-to-Equity Ratio of 2.18, LLY operates with exceptionally high leverage compared to the Pharmaceuticals industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

KO vs. LLY: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Beverages and Pharmaceuticals industry benchmarks.

Interest Coverage Ratio (TTM)

KO

67.13

Beverages Industry

Max
78.96
Q3
42.68
Median
10.96
Q1
3.86
Min
0.81

KO’s Interest Coverage Ratio of 67.13 is in the upper quartile for the Beverages industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.

LLY

20.36

Pharmaceuticals Industry

Max
103.95
Q3
43.60
Median
9.83
Q1
2.37
Min
-42.71

LLY’s Interest Coverage Ratio of 20.36 is positioned comfortably within the norm for the Pharmaceuticals industry, indicating a standard and healthy capacity to cover its interest payments.

KO vs. LLY: A comparison of their Interest Coverage Ratio (TTM) against their respective Beverages and Pharmaceuticals industry benchmarks.

Financial Strength at a Glance

SymbolKOLLY
Current Ratio (MRQ)1.211.28
Quick Ratio (MRQ)0.840.53
Debt-to-Equity Ratio (MRQ)1.732.18
Interest Coverage Ratio (TTM)67.1320.36

Growth

Revenue Growth

KO vs. LLY: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

KO vs. LLY: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

KO

2.95%

Beverages Industry

Max
7.92%
Q3
4.37%
Median
3.32%
Q1
1.98%
Min
0.00%

KO’s Dividend Yield of 2.95% is consistent with its peers in the Beverages industry, providing a dividend return that is standard for its sector.

LLY

0.68%

Pharmaceuticals Industry

Max
7.14%
Q3
3.45%
Median
2.17%
Q1
0.33%
Min
0.00%

LLY’s Dividend Yield of 0.68% is consistent with its peers in the Pharmaceuticals industry, providing a dividend return that is standard for its sector.

KO vs. LLY: A comparison of their Dividend Yield (TTM) against their respective Beverages and Pharmaceuticals industry benchmarks.

Dividend Payout Ratio (TTM)

KO

69.42%

Beverages Industry

Max
188.65%
Q3
104.55%
Median
72.60%
Q1
40.31%
Min
0.00%

KO’s Dividend Payout Ratio of 69.42% is within the typical range for the Beverages industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

LLY

36.46%

Pharmaceuticals Industry

Max
199.58%
Q3
97.17%
Median
53.47%
Q1
22.97%
Min
0.00%

LLY’s Dividend Payout Ratio of 36.46% is within the typical range for the Pharmaceuticals industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

KO vs. LLY: A comparison of their Dividend Payout Ratio (TTM) against their respective Beverages and Pharmaceuticals industry benchmarks.

Dividend at a Glance

SymbolKOLLY
Dividend Yield (TTM)2.95%0.68%
Dividend Payout Ratio (TTM)69.42%36.46%

Valuation

Price-to-Earnings Ratio (TTM)

KO

23.51

Beverages Industry

Max
35.25
Q3
22.66
Median
17.17
Q1
13.65
Min
4.77

A P/E Ratio of 23.51 places KO in the upper quartile for the Beverages industry. This high valuation relative to peers suggests the market holds elevated expectations for the company’s future growth.

LLY

53.86

Pharmaceuticals Industry

Max
45.19
Q3
27.91
Median
20.59
Q1
15.08
Min
3.79

At 53.86, LLY’s P/E Ratio is exceptionally high, exceeding the typical maximum for the Pharmaceuticals industry. This suggests the stock may be significantly overvalued compared to its peers and implies high market expectations that could be difficult to meet.

KO vs. LLY: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Beverages and Pharmaceuticals industry benchmarks.

Price-to-Sales Ratio (TTM)

KO

6.09

Beverages Industry

Max
4.06
Q3
2.24
Median
1.34
Q1
0.86
Min
0.39

With a P/S Ratio of 6.09, KO trades at a valuation that eclipses even the highest in the Beverages industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.

LLY

13.96

Pharmaceuticals Industry

Max
8.87
Q3
4.56
Median
2.14
Q1
1.58
Min
0.11

With a P/S Ratio of 13.96, LLY trades at a valuation that eclipses even the highest in the Pharmaceuticals industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.

KO vs. LLY: A comparison of their Price-to-Sales Ratio (TTM) against their respective Beverages and Pharmaceuticals industry benchmarks.

Price-to-Book Ratio (MRQ)

KO

10.59

Beverages Industry

Max
6.90
Q3
4.23
Median
2.20
Q1
1.51
Min
0.69

At 10.59, KO’s P/B Ratio is at an extreme premium to the Beverages industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

LLY

40.43

Pharmaceuticals Industry

Max
9.78
Q3
4.99
Median
2.48
Q1
1.53
Min
0.59

At 40.43, LLY’s P/B Ratio is at an extreme premium to the Pharmaceuticals industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

KO vs. LLY: A comparison of their Price-to-Book Ratio (MRQ) against their respective Beverages and Pharmaceuticals industry benchmarks.

Valuation at a Glance

SymbolKOLLY
Price-to-Earnings Ratio (TTM)23.5153.86
Price-to-Sales Ratio (TTM)6.0913.96
Price-to-Book Ratio (MRQ)10.5940.43
Price-to-Free Cash Flow Ratio (TTM)43.95369.87